A number of research firms have changed their ratings and price targets for Catalyst Pharmaceuticals (NASDAQ: CPRX): 11/16/2025 – Catalyst Pharmaceuticals was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating. 11/8/2025 – Catalyst Pharmaceuticals was downgraded by analysts at Wall Street Zen from a “buy” rating to a […]